Loading clinical trials...
Loading clinical trials...
Schizophrenia (SCH), major depressive disorder (MDD), and bipolar disorder (BPD) are prevalent, disabling psychiatric conditions that not only cause significant suffering for affected individuals and ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Peking University
NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more
NCT07422519 · Depression - Major Depressive Disorder, Depression Disorder, and more
NCT06878859 · Depression - Major Depressive Disorder, Cannabis Use Disorder, and more
NCT07010614 · Schizophrenia Disorders, Mental Disorder, and more
NCT06641297 · Schizophrenia Disorders
Peking University Sixth Hostipal
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions